CompareMarketResearchRequest a sample
Home / Healthcare / Digital Therapeutics

Healthcare · Market report

Digital Therapeutics Market Size, Share and Forecast 2026-2036

The global digital therapeutics market is worth USD 7.9 bn in 2026 and is forecast to reach USD 49.1 bn by 2036, growing at a 20.0% CAGR. United States is the largest country market and Diabetes and metabolic care is the largest by application segment.

USD 7.9 bnMarket size 2026
USD 49.1 bnForecast 2036
20.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global digital therapeutics market is worth USD 7.9 bn in 2026 and is forecast to reach USD 49.1 bn by 2036, growing at a 20.0% CAGR. United States is the largest country market and Diabetes and metabolic care is the largest by application segment.

ScopeSoftware-based clinical treatments prescribed or recommended for conditions such as diabetes, insomnia, depression, substance use and chronic pain, delivered through apps and connected devices.
IndustryHealthcare
Value 2025USD 6.5 bn
Value 2026USD 7.9 bn
Value 2036USD 49.1 bn
CAGR 2026-203620.0%
Volume 202680.1 million users
Volume 2036548 million users
Average price 2026USD 99.0 per user
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Digital Therapeutics market size and forecast, 2026-2036

Exhibit 1The global digital therapeutics market is forecast to grow from USD 7.9 bn in 2026 to USD 49.1 bn by 2036, more than five times its 2026 sizeGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 20.0%
Digital Therapeutics market value, 2025 to 2036Market value by year. 2025: USD 6.5 bn; 2026: USD 7.9 bn; 2027: USD 9.5 bn; 2028: USD 11.4 bn; 2029: USD 13.7 bn; 2030: USD 16.4 bn; 2031: USD 19.7 bn; 2032: USD 23.7 bn; 2033: USD 28.4 bn; 2034: USD 34.1 bn; 2035: USD 40.9 bn; 2036: USD 49.1 bn. Compound annual growth rate 2026 to 2036: 20.0%.20257.9 bn202619.7 bn203149.1 bn203620.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 7.9 bn
2027USD 9.5 bn
2028USD 11.4 bn
2029USD 13.7 bn
2030USD 16.4 bn
2031USD 19.7 bn
2032USD 23.7 bn
2033USD 28.4 bn
2034USD 34.1 bn
2035USD 40.9 bn
2036USD 49.1 bn

Digital Therapeutics market segmentation

By application

Exhibit 2Diabetes and metabolic care is the largest segment by application, with 34.0% of 2026 revenueEstimated share of 2026 global revenue, by application
Digital Therapeutics market share by application, 2026Share of 2026 revenue by application. Diabetes and metabolic care: 34.0%; Mental health and sleep: 27.0%; Substance use and neurology: 15.0%; Cardiovascular and respiratory: 12.0%; Pain and musculoskeletal: 12.0%.Diabetes and metabolic care34.0%Mental health and sleep27.0%Substance use and neurology15.0%Cardiovascular and respiratory12.0%Pain and musculoskeletal12.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Diabetes and metabolic care34.0%26.6%USD 2.7 bn17.1%
Mental health and sleep27.0%34.7%USD 2.1 bn23.1%
Cardiovascular and respiratory12.0%10.2%USD 952 mn18.1%
Pain and musculoskeletal12.0%12.1%USD 952 mn20.1%
Substance use and neurology15.0%16.4%USD 1.2 bn21.1%

By channel

Exhibit 3Prescription and payer-reimbursed adds the most revenue by channel, growing from USD 3.6 bn in 2026 to USD 27.0 bn by 2036Estimated revenue in USD by channel, 2026 and 2036 forecast
Digital Therapeutics market by channel, 2026 and 2036Revenue by channel in 2026 and 2036. Prescription and payer-reimbursed: USD 3.6 bn in 2026, USD 27.0 bn in 2036, change +656%; Employer and health plan programs: USD 2.8 bn in 2026, USD 12.7 bn in 2036, change +359%; Direct to consumer: USD 1.6 bn in 2026, USD 9.4 bn in 2036, change +491%.20262036 forecastChangePrescription and payer-reimbursed+656%3.6 bn27.0 bnEmployer and health plan programs+359%2.8 bn12.7 bnDirect to consumer+491%1.6 bn9.4 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Prescription and payer-reimbursed45.0%55.0%USD 3.6 bn22.4%
Employer and health plan programs35.0%25.9%USD 2.8 bn16.5%
Direct to consumer20.0%19.1%USD 1.6 bn19.4%

By platform

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Smartphone apps64.0%62.0%USD 5.1 bn19.6%
Web-based programmes14.0%12.0%USD 1.1 bn18.2%
Wearable-integrated12.0%16.0%USD 952 mn23.5%
Virtual reality and other10.0%10.0%USD 793 mn20.0%

By therapeutic approach

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Cognitive behavioural programmes30.0%28.0%USD 2.4 bn19.2%
Lifestyle and behaviour coaching34.0%30.0%USD 2.7 bn18.5%
Neuromodulation and gamified therapy16.0%20.0%USD 1.3 bn22.7%
Adherence and monitoring support20.0%22.0%USD 1.6 bn21.1%

By patient age group

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Adults 18 to 6454.0%50.0%USD 4.3 bn19.1%
Seniors 65 and over26.0%30.0%USD 2.1 bn21.7%
Children and adolescents20.0%20.0%USD 1.6 bn20.0%

Top 25 countries for digital therapeutics by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 93.5% of 2026 revenue and the 25 countries below together hold 98.7%.

Exhibit 4United States is the largest country market at USD 4.0 bn in 2026, and the three largest countries hold 65.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Digital Therapeutics market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 4.0 bn, 50.0%; Germany: USD 634 mn, 8.0%; China: USD 555 mn, 7.0%; Japan: USD 476 mn, 6.0%; United Kingdom: USD 476 mn, 6.0%; France: USD 317 mn, 4.0%; South Korea: USD 317 mn, 4.0%; Canada: USD 238 mn, 3.0%; India: USD 238 mn, 3.0%; Australia: USD 198 mn, 2.5%.United States4.0 bn 50.0%Germany634 mn 8.0%China555 mn 7.0%Japan476 mn 6.0%United Kingdom476 mn 6.0%France317 mn 4.0%South Korea317 mn 4.0%Canada238 mn 3.0%India238 mn 3.0%Australia198 mn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 4.0 bn50.0%USD 21.2 bn18.3%
2GermanyUSD 634 mn8.0%USD 5.1 bn23.2%
3ChinaUSD 555 mn7.0%USD 4.5 bn23.2%
4JapanUSD 476 mn6.0%USD 2.7 bn19.2%
5United KingdomUSD 476 mn6.0%USD 3.0 bn20.2%
6FranceUSD 317 mn4.0%USD 2.2 bn21.1%
7South KoreaUSD 317 mn4.0%USD 2.2 bn21.1%
8CanadaUSD 238 mn3.0%USD 1.4 bn19.2%
9IndiaUSD 238 mn3.0%USD 2.7 bn27.3%
10AustraliaUSD 198 mn2.5%USD 1.1 bn19.0%
11NetherlandsUSD 42 mn0.5%USD 231 mn18.6%
12SwitzerlandUSD 36 mn0.5%USD 206 mn18.9%
13SwedenUSD 36 mn0.5%USD 206 mn18.9%
14SpainUSD 31 mn0.4%USD 177 mn19.0%
15ItalyUSD 31 mn0.4%USD 177 mn19.0%
16SingaporeUSD 31 mn0.4%USD 221 mn21.7%
17IsraelUSD 31 mn0.4%USD 177 mn19.0%
18BrazilUSD 26 mn0.3%USD 182 mn21.4%
19AustriaUSD 26 mn0.3%USD 147 mn18.9%
20DenmarkUSD 26 mn0.3%USD 147 mn18.9%
21NorwayUSD 21 mn0.3%USD 118 mn19.0%
22BelgiumUSD 21 mn0.3%USD 118 mn19.0%
23FinlandUSD 21 mn0.3%USD 118 mn19.0%
24Saudi ArabiaUSD 16 mn0.2%USD 108 mn21.1%
25MexicoUSD 16 mn0.2%USD 108 mn21.1%
Rest of worldUSD 105 mn1.3%USD 653 mn20.1%
Exhibit 5United States and Germany account for 53% of the USD 41.2 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Digital Therapeutics market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 7.9 bn. United States: +USD 17.2 bn; Germany: +USD 4.5 bn; China: +USD 3.9 bn; United Kingdom: +USD 2.5 bn; India: +USD 2.4 bn; 20 other countries: +USD 10.1 bn; Rest of world: +USD 548 mn. Market value 2036: USD 49.1 bn.Market value 20267.9 bnUnited States+17.2 bnGermany+4.5 bnChina+3.9 bnUnited Kingdom+2.5 bnIndia+2.4 bn20 other countries+10.1 bnRest of world+548 mnMarket value 203649.1 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Omada Health
  • Teladoc Health
  • Welldoc
  • Click Therapeutics
  • Hinge Health
  • Virta Health

Group 2: Regional and specialist players

  • Big Health
  • Kaia Health
  • CureApp
  • Sidekick Health
  • Sword Health
  • Ieso Digital Health
  • Biofourmis

Group 3: Emerging and niche players

  • DarioHealth
  • Orexo
  • Wysa
  • Freespira
  • Luminopia

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the digital therapeutics market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 20.0% is calculated from the resulting values.

The market is divided by application, by channel, by platform, by therapeutic approach, by patient age group. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the digital therapeutics market?

The global digital therapeutics market is estimated at USD 6.5 bn in 2025 and USD 7.9 bn in 2026.

How fast will the digital therapeutics market grow?

It is forecast to reach USD 49.1 bn by 2036, a compound annual growth rate of 20.0% from 2026, an increase of USD 41.2 bn.

Which country is the largest market for digital therapeutics?

United States is the largest market by revenue at USD 4.0 bn in 2026, 50.0% of the global total. The three largest countries together hold 65.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 27.3% a year from 2026 to 2036.

Which digital therapeutics segment is largest?

In the by application split, Diabetes and metabolic care is the largest segment with 34.0% of 2026 revenue.

Who are the leading digital therapeutics companies?

Global leaders include Omada Health, Teladoc Health, Welldoc, Click Therapeutics.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Digital Stethoscope Digital Twins Technologies →

All Healthcare markets →

Request a sample